← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Quintessence Biosciences, Inc.
Madison, WI
$1,746,769
Total funding
6
Grants
Funding over time
peak $634.1K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,746,769 · 6
By mechanism
R44$986,857 · 1
R43$414,545 · 3
R21$175,000 · 1
N43$170,367 · 1
Investigators at Quintessence Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Improving Efficacy of RNase Cancer Therapy by Pharmacokinetics$634,106
R44 · FY2009 · CA
Improving Efficacy of RNase Cancer Therapy by Pharmacokinetics$352,751
R44 · FY2010 · CA
HTS Assay to Profile Glucuronidation of Small Molecules$175,000
R21 · FY2005 · NS
402 - RFP: N43-CM-87007-68 Topic 251: Development of Anticancer Agents Reques$170,367
N43 · FY2008 · CA
Cytotoxic Ribonucleases in Antibody-Drug Conjugates$157,739
R43 · FY2007 · CA
SPR Microarrays for Drug Absorption Profiling$131,199
R43 · FY2006 · GM
Improving Efficacy of RNase Cancer Therapy by Pharmacokinetics$125,607
R43 · FY2007 · CA